Logo

    arbisser

    Explore " arbisser" with insightful episodes like "Buttonhole Posterior Capsule IOL Implantation: Interview with Rupert Menapace, MD", "Customized IOLs for Spherical Aberration: Interview with George Beiko, BM, BCh, FRCSC" and "Aganocides - The Future of Antimicrobials: Interview with Stephen Wilmarth, MD" from podcasts like ""American Academy of Ophthalmology Podcasts", "American Academy of Ophthalmology Podcasts" and "American Academy of Ophthalmology Podcasts"" and more!

    Episodes (3)

    Buttonhole Posterior Capsule IOL Implantation: Interview with Rupert Menapace, MD

    Buttonhole Posterior Capsule IOL Implantation: Interview with Rupert Menapace, MD
    A conversation between Lisa B. Arbisser, MD, and Rupert Menapace, MD. Dr. Menapace discusses his alternative to in-the-bag IOL implantation: buttonholing the IOL into the posterior capsule. His experience with more than 1,000 cases shows the technique prevents posterior capsular opacification and significantly reduces fibrosis. (August 2010)

    Customized IOLs for Spherical Aberration: Interview with George Beiko, BM, BCh, FRCSC

    Customized IOLs for Spherical Aberration: Interview with George Beiko, BM, BCh, FRCSC
    A conversation between Lisa B. Arbisser, MD, and George Beiko, BM, BCh, FRCSC, on customized IOLs for spherical aberration. Surgeons now have the opportunity to choose an IOL that best fits an individual patient’s corneal asphericity. Dr. Beiko, a leader in the field of spherical aberration correction, discusses the nuances of optimizing visual acuity. (June 2010)

    Aganocides - The Future of Antimicrobials: Interview with Stephen Wilmarth, MD

    Aganocides - The Future of Antimicrobials: Interview with Stephen Wilmarth, MD
    A conversation between Lisa B. Arbisser, MD, and Stephen Wilmarth, MD, on the future of synthetic antimicrobials. Dr. Stephen Wilmarth, chairman of the ophthalmic development committee at NovaBay Pharmaceuticals, discusses synthetic antimicrobials called Aganocides that may deliver the same or better efficacy than antibiotics without triggering antibiotic-resistance. (March 2010)
    Logo

    © 2024 Podcastworld. All rights reserved

    Stay up to date

    For any inquiries, please email us at hello@podcastworld.io